Cancer Related News
New biomarker identified to diagnose pancreatic cancer
A new biomarker – a protein called pentraxin 3 (PTX3) – has been identified that could be used to aid in the diagnosis of...
Promising bladder cancer treatment developed using alternative approach
Using a new approach to molecular drug design, scientists have created a highly promising bladder cancer treatment.
The new drug to treat bladder cancer was...
Collaboration formed to test efficacy of breast cancer therapy
Defence Therapeutics Inc. has announced the establishment of a collaboration with the Curie Institute to evaluate the therapeutic efficacy of Accum-T-DM1 ADC in patient-derived...
Defence Therapeutics: Transforming drug delivery and improving treatment
Defence Therapeutics is continuously expanding on its portfolio of solutions to enhance drug delivery and improve treatment outcomes for patients with cancer and infectious...
Scientific breakthrough could increase rhabdomyosarcoma survival rates
A new genetic discovery could lead to improvements in treatment and increased survival rates for the aggressive cancer rhabdomyosarcoma.
Rhabdomyosarcoma is a rare type of...
Revolutionising blood management for cancer surgery
Lindis Blood Care is aiming to revolutionise blood management for cancer surgery with its medical device CATUVAB®.
CATUVAB® aids with the removal of tumour cells...
Statin use reduced risk of cancer in heart failure patients
Statin use can lessen the risk of cancer and mortality in heart failure patients, new research has found.
Academics at the University of Hong Kong...
Defence Therapeutics Accutox exhibits potent anti-cancer properties
Defence Therapeutics Inc. has announced a major breakthrough advance in its pre-clinical research program on its AccuTOX molecules as potent anti-cancer agents.
The AccumTM technology...
Blood test could help improve post-surgery bladder cancer treatment
A blood test could identify the risk of cancer recurrence and guide precision treatment in bladder cancer, new research suggests.
A clinical study, led by...
Defence Therapeutics technology holds promise for future cancer therapy
Canadian biotechnology company Defence Therapeutics has developed a new generation platform technology that offers hope for future cancer therapy.
Defence Therapeutics’ ACCUM™ technology can be...
Towards a cancer revolution with new targeted therapeutics
Defence Therapeutics Inc’s proprietary new platform offers a revolution in drug delivery.
Quebec-based biotechnology developer Defence Therapeutics Inc specialises in antibody-drug conjugates (ADCs), a novel...
New app offers round-the-clock support for cancer patients
Incorporating expert cancer information from Macmillan Cancer Support, a new app has been launched to support cancer patients.
The Unify Health resource, developed by Accord...
Defence therapeutics vaccine against cancer makes progress
Defence Therapeutics has recently reported its first successes in the fight against cancer with a vaccine.
Defence Therapeutics is a Canadian scientific pioneer, uncovering enhanced...
Collaboration established for the optimisation of cancer therapeutic
Defence Therapeutics Inc. has established a collaboration with the HUS Comprehensive Cancer Center at Helsinki, Finland, for the optimisation of Defence’s Accum-T-DM1 ADC Therapeutic.
Defence...
£8m project will create robots to spot and remove cancer tumours
A new £8m project has been launched to develop robotic technology that can detect and remove cancer tumours.
Led by scientists at the University of...
Women may have more protection from skin cancer than men
Women’s immune response may offer greater protection to some forms of skin cancer than in men, new research has found.
Early research on mice and...
Study shows potential for earlier pancreatic cancer diagnosis
Machine learning could aid an earlier pancreatic cancer diagnosis and increase patient survival numbers, new research has found.
A study, led by the London School...
Cutting the fuel supply to cells can prevent cancer spreading
Halting the energy supply to certain cells can help to stop the spread of cancer, researchers have discovered.
A study by scientists from the Translational...
Positive patient reported outcomes for prostate cancer therapy
Results from the Phase III TITAN study final analysis have confirmed the survival benefit achieved with the addition of apalutamide to androgen deprivation therapy...
Patient reports of signs of cancer fell during first wave of pandemic
The reporting of possible signs of cancer decreased during the first wave of the COVID-19 pandemic, new research has found.
The public is being urged...